IVZ reports Tuesday, Jan 26, 2027, before the open. After the last 4 reports the stock moved −0.4%, −2.3%, +1.5%, −5.1% the next day.
EPS 0.72 against an estimate of 0.74 (−2.5% surprise). The stock moved −0.4% the next trading day.
IVZ is expected to report on Tuesday, Jan 26, 2027, before the open (US Eastern time).
| Report | EPS est. | EPS | Next day | Week |
|---|---|---|---|---|
| Oct 27, 2026 | 0.74 | 0.72 | −0.4% | −2.7% |
| Jul 28, 2026 | 0.66 | 0.71 | −2.3% | +2.7% |
| Apr 28, 2026 | 0.58 | 0.57 | +1.5% | +2.2% |
| Jan 27, 2026 | 0.58 | 0.62 | −5.1% | −4.3% |
| Oct 28, 2025 | 0.44 | 0.61 | +2.1% | +0.5% |
| Jul 22, 2025 | 0.40 | 0.36 | +5.2% | +7.3% |
| Apr 22, 2025 | 0.39 | 0.44 | +8.3% | +11.9% |
| Jan 28, 2025 | 0.47 | 0.52 | +9.0% | +3.3% |
Average move the next trading day over the last 8 reports: ±4.2% (5 of 8 up).
IVZ is in a turning up, momentum firm. $28.65 is the level overhead; $27.97 the first support below.
IVZ at $28.26. Nearest resistance $28.65 (+1.4%). Nearest support $27.97 (−1.0%).
IVZ chart, levels and analysis · Earnings this week
IVZ is expected to report on Tuesday, Jan 26, 2027, before the open.
IVZ reports before the open, US Eastern time.
After its report on Oct 27, 2026, IVZ moved −0.4% the next trading day.
Over the last 8 reports, IVZ moved 4.2% on average the next trading day, up 5 times out of 8.